. of P e d i a t r i c s , Winston-Salem, N.C. HPA i s a unique metabolic disorder previously described i n only 2 unrelated i n f a n t s . A 5 mo. old male (Pt. 2) was suspected of having HPA when he presented with hepatomegaly, retinopathy and developmental delay. A previous s i b , a l s o male (Pt. 1 ) died a t 18 mo. with a s i m i l a r disorder progressing t o l i v e r f a i l u r e and s e i z u r e s . The diagnosis of HPA was supported i n P t . 2 by a serum pipecolic acid (PA) l e v e l of 1.10 mg% ( n l .17 2 .05) and confirmed by a markedly abnormal response t o an o r a l PA loading study. Since PA is a metabolite of l y s i n e , p r o t e i n r e s t r i c t i o n was begun and decreasing intake of p r o t e i n was accompanied by decreasing serum PA. On 0.9 g/kg/day, however, serum PA remains 2-3 x normal. The p t . has grown well and has had no apparent progression of h i s l i v e r d i s e a s e but remains developmentally delayed and v i s u a l l y impaired a t age 14 mo.
serum pipecolic acid (PA) l e v e l of 1.10 mg% ( n l .17 2 .05) and confirmed by a markedly abnormal response t o an o r a l PA loading study. Since PA is a metabolite of l y s i n e , p r o t e i n r e s t r i c t i o n was begun and decreasing intake of p r o t e i n was accompanied by decreasing serum PA. On 0.9 g/kg/day, however, serum PA remains 2-3 x normal. The p t . has grown well and has had no apparent progression of h i s l i v e r d i s e a s e but remains developmentally delayed and v i s u a l l y impaired a t age 14 mo.
The PA l e v e l i n frozen l i v e r from Pt. 1 was 2.41 mg/g p r o t ( n l .36-.87).
Unique pathologic changes were found i n l i v e r and f i b r o b l a s t s from P t s . 1 & 2 and i n b r a i n from Pt. 1.
Unless suspected c l i n i c a l l y , HPA may be missed by r o u t i n e met-: a b o l i c screening. 2-dimensional TLC revealed a PA spot i n the urine of Pta. 1 & 2 but no PA peak was detected i n serum o r urine on an autoanalyzer. HPA is c l i n i c a l l y s i m i l a r t o Zellweger's syndrome which has a l s o been associated with elevated serum and u r i n e PA i n some p a t i e n t s . The primary metabolic defect i n these disorders may be c l o s e l y r e l a t e d . The sudden p o t e n t i a l l y f a t a l episode occurring i n the young Mg d e f i c i e n t r a t appears t o be a form o f shock w i t h neurological components; the pathogenesis i s unknown. Pathologic changes in-, clude acute pulmonary edema, which may be hemorrhagic (Ped. Res. 12:1157 Res. 12: ,1978 ; t h i s suggested the possible r o l e o f massive cate-I c h o l amine release i n t h i s syndrome (Cheng, Cardiovasc Res. 9:105-11, 1975) . Male weanling 35 g r a t s were fed p u r i f i e d d i e t s w i t h 40% casein and s u f f i c i e n t (S) Mg (150.8+1.1 mg/100 g(3)) o r defic i e n t (D) (6.0+0.1 mg/100 g) (3). Group D r a t s became h y p e r i r r i b able; o f 10, three died spontaneously between days 10 and 12. On days 12 t o 13, u r i n e was collected i n 7 r a t s per group and anslyzed f o r 24 h r catecholamines. Bone Mg was determined by atomic absorption spectrophotometry. US Bureau Stds. 1 i v e r was reference. (variant) was r e c e n t l y shown t o respond t o viokase which contains PA (KriegerbEvans, J.Pediatr.96:32,80). It promotes Zn absorption i n the r a t and concentrations i n human milk a r e 20x higher than i n cow's milk(Evans, Pediatrfies.l4:876, 80). The p a t i e n t was t r e a t e d sucessfu y with 60mg Zn a s t h e s u l -44 f a t e , then f o r 5 mo. with ZnPA(5mg Zn )and 3 mo. with 8-20mg PA. Both maintained plasma Zn around 150)1g/dl(N:112213). This prompted a t r i a l of ZnPA i n 3 p a t i e n t s with "classical"AE.The minimum therapeutic dose of Zn s u l f a t e t h a t maintained normal plasma Zn was f i r s t determined and then discontinued u n t i l $he rash appeared. ZnPA was then given, using 113 dose of Zn . This caused rapid improvement and has maintained normalcy f o r 4-6 weeks.
Plasma PA was measured i n 2 AE a n d a v a r i a n t AE cases,age 1 t o 9 yrs, while they were on 30-45mg Zn a s t h e s u l f a t e and well.
Normal:l.2-2.0pmoles/d1(4 children, 1 0 a d u l t s ) . Plasma PA i n AE was 0.05b0.45 pmolesldl, and i n v a r i a n t AE 0.02-0.69 pmoles/dl. These values were thus f a r below t h e normal range. Some variabil i t y can be a t t r i b u t e d t o d i f f e r e n t d i e t a r y content of PA s i n c e i t was shown t h a t o r a l PA r a i s e s plasma PA(in 1 case of AE from 0.05-1.24 ,umoles/dl). These d a t a i n d i c a t e t h a t ZnPA decreases t h e requirements f o r Zn i n AE, presumably because i t a c t s a s a ligand. A genetic defect of PA metabolism may be the cause of AE. Neither PA nor ZnPA a r e recommended f o r treatment u n t i l the metabolism of t h i s tryptophan metabolite is b e t t e r understood. It has r e c e n t l y been suggested t h a t t h e hypercalcemia of pulmonary sarcoidosis could be r e l a t e d t o high c i r c u l a t i n g l e v e l s of 1,250H2D (Bell e t a l , JCI 64:218, 1978; Papapoulos e t a l , Lanc e t i:627, 1979). However, t h i s hypothesis has not been tested i n a c h i l d . The evaluation of serum calcium l e v e l s of 12.4 t o 14.8 mgldl i n a 9-year-old g i r l revealed a low normal immunoreact i v e PTH l e v e l , hypercalcuria, an abnormal CaICr r a t i o (0.81) and a c r e a t i n i n e clearance of 20.5 ml/min/1.73 M~. Because of hepatomegaly, cutaneous anergy and the presence of n a t i v e macrophage suppressor a c t i v i t y , a l i v e r biopsy was performed which revealed non-caseating granulomata. Vitamin D metabolite l e v e l s were: 250H-D of 27-45 nglml ( n l 3 e 5 , SD); 24,250H2D of 2.3-2.7 nglml ( n l 1.7fP.5), and 1,250H2D of 91 and 75 pglml ( n l 4 2 5 5 ) . Despite hypercalcemia, 1,250H2D l e v e l s were g r e a t e r than +2 SD above mean value f o r age. Prednisone therapy (2 mglkglday) lowered serum Ca, urinary CaICr r a t i o and Ca excretion (388 t o 182 mglday), and Clcr rose t o 128 ml/min/1.73 M~. Levels of 1,250H2D f e l l t o 23 and 28 pglml. The finding i n t h i s and other a d u l t s with sarcoidosis suggests t h a t hypercalcemia and hyperc a l c u r i a a r e r e l a t e d t o elevated c i r c u l a t i n g 1,250H2D l e v e l s . Serum elevations occur independent of PTH or other vitamin D metabolite l e v e l s and 1,250H2D overproduction and hypercalcemia i n sarcoidosis can be reversed by glucocorticoids. The concentrations of 250H-D (n=62) and 1,250H2D (n=231) were measured i n the s e r a of normal subjects aged 18 months t o 35 years. Samples were obtained i n a l l months of the year t o a s s e s s the e f f e c t of t h e seasons on serum concentration. Serum 250HD3 was 16.327.0 nglml (SE) i n Jan.-March and rose t o 24.457.6 i n April-June and t o 31.258.5 i n July-Sept., p < .001. I n 0ct.-Dec. (TG) responded rapidly t o a l t e r a t i o n s i n zinc n u t r i t i o n a l s t a t u s . After 7 days on Zn-d i e t (Zn 1 ppm), TG were increased by 200%, whereas i n r a t s fed a control (C) d i e t (100 ppm) no changes i n TG l e v e l s were recorded. By continuing the Zn-d i e t the TG increased gradually t o 600% of the i n i t i a l value a f t e r day 28, when TG leveled o f f . Thus, the elevation i n TG preceded c l i n i c a l signs of Zn-, and the elevation i n TG is higher i n the more severely d e f i c i e n t r a t s . Zn-r a t s fed t h e C d i e t o r a Zn enriched (Zn +) d i e t (500 ppm) were r e p l e t e d with Zn rapidly and TG decreased t o normal values. Thus, hypertriglyceridemia (HTG) of Zn-i s r e v e r s i b l e when d i e t a r y Zn i s increased and body s t o r e s of Zn a r e repleted. The HTG may be r e l a t e d t o the decrease i n post heparin plasma lipoprotein l i p a s e between Zn-(370 * 98 DPM glyc e r o l releaselmg protein130 min) and C (510 + 124). To t e s t the hypothesis t h a t Zn-r a t s have a higher l e v e l of endogenous l i p i d production, i n v i t r o l i v e r metabolism experiments were undertaken. Liver s l i c e s were incubated with ( 1 4~) glucose o r (14c) ~ palmitate and t h e i r u t i l i z a t i o n f o r TG synthesis and 1 4~0 2 production was measured. The r e s u l t s showed higher incorporation i n t o T G i n Zn-r a t s which may be due t o an abnormality i n carbohydrate metabolism.
LACK OF SEASONAL VARIATION

